Australian biotech market today 31.03.09

By Kate McDonald
Tuesday, 31 March, 2009

A very flat day on the stock markets today, with the All Ordinaries down 0.2 per cent at 1.30pm. Pharma and biotech indices were one of the few in the positive, rising 0.68 per cent.

Pharmaxis (ASX:PXS) was up 11c to a healthy $1.71.

Cochlear (ASX:COH) and CSL (ASX:CSL) are both up, as is HeartWare (ASX:HIN) and ResMed (ASX:RMD).

Sirtex Medical (ASX:SRX) is down slightly, as is Progen (ASX:PGL).

Noxopharm says paper reveals science behind its immune system platform

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...

Neurosensing/neurostimulation implants session to be held on Monday

On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...

Content from other channels on our network

Abattoir safety program in WA raises more awareness

Closing the loop with food packaging made from fish skin waste

Electric trucks hit the road to deliver beer in Perth

Fonterra announces Mainland Group leadership change

Barry Callebaut opens chocolate innovation centre in Singapore

Liquid metal to 'harvest' clean hydrogen from water

Epson makes progress with sustainability plans and initiatives in Australia and New Zealand

Sustainable wastewater treatment achieved for urban areas

'Brownfielding' increases to meet metal demand

NSW to exceed energy storage targets

Why physical device security is becoming a patient privacy issue in health care

Food waste in Australian hospitals and aged care homes — can AI help?

InterSystems Honoured with Four 2026 Best in KLAS Awards

How do different types of pain influence empathy?

St Vincent's Hospital Sydney junior doctors class action underway